JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB108745

人Anti-Influenza virus A IgG ELISA试剂盒

Human Anti-Influenza virus A IgG ELISA Kit

Be the first to review this product! Submit a review

|

(3 Publications)

Human Anti-Influenza virus A IgG ELISA Kit is an indirect ELISA for the qualitative detection of IgG class antibodies against Influenza virus A in human plasma and serum samples.

- Colorimetric readout - 450 nm - Works on any standard plate reader
- Easy results interpretation
- Cut-off, positive and negative controls included

关键信息

检测方法

Colorimetric

样品类型

Citrate plasma, Heparin Plasma, Serum

反应种属

Human

检测类型

Indirect

检测平台

Microplate

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

产品详情

Human Anti-Influenza virus A IgG ELISA Kit is an indirect ELISA for the qualitative detection of IgG class antibodies against Influenza virus A in human plasma and serum samples.

How the assay works:

A 96-well plate has been precoated with Influenza virus A antigens to ind cognate antibodies. Controls or test samples are added to the wells and incubated. Following washing, a horseradish peroxidase (HRP) labelled anti-Human IgG conjugate is added to the wells, which binds to the immobilized Influenza virus A-specific antibodies. TMB is then catalyzed by the HRP to produce a blue color product that changes to yellow after adding an acidic stop solution. The density of yellow coloration is directly proportional to the amount of Influenza virus A IgG sample captured in plate.

Assay Specificity

Our ELISA kits are rigorously validated to ensure the highest level of consistency and reproducibility. Please check the protocol booklet for more details

Human Anti-Influenza virus A IgG ELISA Kit ab108745 protocol summary

1. Add samples and controls to wells used. Incubate at 37°C

2. Wash each well and add prepared labeled HRP-Conjugate. Incubate at room temperature
3. After washing, add TMB substrate solution to each well. Incubate at room temperature
4. Add Stop Solution to each well. Read immediately.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

精确度

[ { "reproducibilityType": "Inter", "sample": "Serum", "replicates": 12, "mean": null, "standardDeviation": null, "coefficientOfVariability": "3.2" }, { "reproducibilityType": "Inter", "sample": "Serum", "replicates": 12, "mean": null, "standardDeviation": null, "coefficientOfVariability": "2.1" }, { "reproducibilityType": "Intra", "sample": "Serum", "replicates": 20, "mean": null, "standardDeviation": null, "coefficientOfVariability": "4.5" }, { "reproducibilityType": "Intra", "sample": "Serum", "replicates": 24, "mean": null, "standardDeviation": null, "coefficientOfVariability": "3.3" } ]

规格

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab108745-1x96Tests", "assetComponentDetails": [ { "size":"1 x 2 mL", "name":"Influenza virus A IgG Negative Control", "number":"AB108745-CMP05", "productcode":"" }, { "size":"1 x 3 mL", "name":"Influenza virus A IgG Cut-off Control", "number":"AB108745-CMP04", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Influenza virus A (IgG) Coated Microplate (12 x 8 wells)", "number":"AB108745-CMP06", "productcode":"" }, { "size":"1 x 20 mL", "name":"Influenza virus A anti-IgG HRP Conjugate", "number":"AB108745-CMP07", "productcode":"" }, { "size":"1 x 15 mL", "name":"TMB Substrate Solution", "number":"AB108745-CMP02", "productcode":"" }, { "size":"1 x 100 mL", "name":"IgG Sample Diluent", "number":"AB108745-CMP01", "productcode":"" }, { "size":"1 x 50 mL", "name":"20X Washing Solution", "number":"AB108745-CMP03", "productcode":"" }, { "size":"1 x 15 mL", "name":"Stop Solution", "number":"AB108745-CMP09", "productcode":"" }, { "size":"1 x 2 mL", "name":"Influenza virus A IgG Positive Control", "number":"AB108745-CMP08", "productcode":"" } ] } } }

性能和储存信息

运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C
储存信息
+4°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

Influenza virus A IgG is an immunoglobulin G antibody that targets influenza virus A. Immunoglobulins are critical components of the immune system often used as diagnostic markers. The mass of IgG varies due to its complex structure generally around 150 kDa. This antibody is primarily expressed by B lymphocytes in response to influenza virus infection and plays a central role in identifying and neutralizing virus particles. The utilization of IgG in applications like Influenza ELISA test and Influenza assay kits highlights its importance in laboratory settings.
Biological function summary

The influenza virus IgG antibody binds specifically to antigens present on the influenza virus A tagging them for destruction by other immune cells. It does not typically form part of larger protein complexes but operates in concert with other components of the immune system like macrophages and natural killer cells to neutralize the virus. The presence and quantity of influenza IgG antibodies are pivotal indicators of past exposure or vaccination against flu virus A in ELISA testing.

Pathways

This antibody fits into the immune system pathway where it plays a role in activating the classical complement pathway. This pathway leads to opsonization of the virus therefore improving phagocytosis efficacy by macrophages. Additionally influenza virus A IgG interacts with Fc receptors on immune effector cells facilitating processes such as antibody-dependent cellular cytotoxicity (ADCC). These interactions highlight the relationship between influenza IgG and other immune receptors in mounting an effective response.

The influenza virus A IgG is closely related to influenza a respiratory illness caused by the influenza virus A. Monitoring IgG levels can help assess immunity status and guide vaccination strategies. Furthermore disturbances in IgG production might correlate with immune-related disorders such as immunodeficiencies or allergies. The presence of IgG is pivotal for the diagnosis and management of influenza and sometimes connects to adaptive immune responses involving proteins like the T-cell receptor during immune system adaptations.

产品实验方案

靶点信息

文献 (3)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in nutrition 10:1116634 PubMed37168053

2023

Healthy adults supplemented with a nutraceutical formulation containing gel, rosemary and enhances the effect of influenza vaccination in a randomized, triple-blind, placebo-controlled trial.

Applications

Unspecified application

Species

Unspecified reactive species

Erin D Lewis,David C Crowley,Najla Guthrie,Malkanthi Evans

Vaccines 10: PubMed35891309

2022

Adults with Trisomy 21 Have Differential Antibody Responses to Influenza A.

Applications

Unspecified application

Species

Unspecified reactive species

Stephanie James,Robert C Haight,Cassandra Hanna,Lindsey Furton

Nature medicine 25:591-596 PubMed30886409

2019

The repertoire of maternal anti-viral antibodies in human newborns.

Applications

Unspecified application

Species

Unspecified reactive species

Christian Pou,Dieudonné Nkulikiyimfura,Ewa Henckel,Axel Olin,Tadepally Lakshmikanth,Jaromir Mikes,Jun Wang,Yang Chen,Anna Karin Bernhardsson,Anna Gustafsson,Kajsa Bohlin,Petter Brodin
View all publications
websiteProtocolBooklet
en

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com